Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Impact of COVID-19 Lockdown on Metabolic Control in Individuals With Type 2 Diabetes

NCT04501991 is registered in ClinicalTrials.gov with University of Pisa as lead sponsor.

NCT NCT04501991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04501991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Impact of COVID-19 Lockdown on Metabolic Control in Individuals With Type 2 Diabetes
Lead sponsor
University of Pisa
Phase
Observational
Overall status
Completed
Start date
March 11, 2020
Completion date
June 30, 2020
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic control, type 2 diabetes